Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Bruker Corp (BRKR)
NASDAQ:BRKR
Earnings Data
Report Date
Apr 30, 2025TBA Not Confirmed
Period Ending
2025 (Q1)Consensus EPS Forecast
0.42Last Year’s EPS
0.53Same Quarter Last Year
Moderate Buy
Based on 11 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:Feb 13, 2025
|% Change Since: -1.74%
|Next Earnings Date:Apr 30, 2025
Earnings Call Sentiment|Neutral
Bruker's earnings call highlighted strong revenue growth and strategic acquisition successes, positioning the company well for future growth. However, challenges such as NIH funding uncertainty, China market softness, and initial M&A dilution present headwinds. Despite these challenges, the company remains focused on margin expansion and EPS growth.Company Guidance
During the Bruker Corporation's Fourth Quarter 2024 Earnings Conference Call, the company outlined its financial guidance for the fiscal year 2025. Bruker expects constant exchange rate (CER) revenue growth of 5% to 7%, with organic growth anticipated at 3% to 4% and acquisitions contributing an additional 2% to 3%. The company also projects a 140 basis points (bps) improvement in non-GAAP operating profit margins, building on the 15.4% margin achieved in 2024. Furthermore, Bruker forecasts non-GAAP EPS growth of 11% to 13%, translating to a 14% to 16% increase when adjusted for constant exchange rates. These expectations are supported by a healthy backlog, strategic acquisitions in spatial biology, molecular diagnostics, and lab automation, and strong market trends in diagnostics and semiconductor metrology. However, the guidance also accounts for potential uncertainties in the U.S. NIH and academic government markets.Strong Revenue Growth
Bruker reported revenues increased by 14.6% year-over-year in Q4 2024 to $979.6 million, with a constant exchange rate (CER) revenue growth of 15.8% and organic growth of 3.9%.
Above-Market Organic Growth
For fiscal year 2024, Bruker achieved a 4% organic revenue growth, outperforming the market, which was flat to down slightly.
Successful Strategic Acquisitions
Bruker added strategic platforms in spatial biology, molecular diagnostics, and lab automation, contributing to a 10% revenue growth from acquisitions.
Microbiology and Semiconductor Metrology Growth
The microbiology and infectious diagnostics business grew in the mid-teens percentage in Q4, while semiconductor metrology experienced over 20% organic growth.
Improved Operating Margins
Bruker achieved a non-GAAP operating margin of 18.1% in Q4, driven by 300 bps of organic operating margin expansion.
---
BRKR Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
BRKR Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Feb 13, 2025 | $51.65 | $51.15 | -0.97% |
| Nov 05, 2024 | $59.30 | $61.29 | +3.36% |
| Aug 06, 2024 | $63.44 | $62.06 | -2.18% |
| May 02, 2024 | $78.84 | $69.92 | -11.31% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does Bruker Corp (BRKR) report earnings?
Bruker Corp (BRKR) is schdueled to report earning on Apr 30, 2025, TBA Not Confirmed.
What is Bruker Corp (BRKR) earnings time?
Bruker Corp (BRKR) earnings time is at Apr 30, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is BRKR EPS forecast?
BRKR EPS forecast for the fiscal quarter 2025 (Q1) is 0.42.
---